US 12098385
Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy
granted A61KA61K35/34A61K38/17
Quick answer
US patent 12098385 (Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy) held by The Regents of the University of California expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K35/34, A61K38/17, A61K38/177, A61K48/005